Literature DB >> 7259276

Variability of airways hyper-reactivity and allergy in cystic fibrosis.

F J Holzer, A Olinsky, P D Phelan.   

Abstract

The importance of bronchial hyper-reactivity and allergy, and treatment with bronchodilators and corticosteroids, in the management of patients with cystic fibrosis is poorly understood. Three tests generally regarded as useful in the diagnosis of asthma were evaluated in 25 children with cystic fibrosis. The constancy of a child's response was assessed by histamine bronchial provocation, exercise challenge, and tests of skin allergy during a 6-month period. Although a positive response to these tests was related to impaired pulmonary function, 44% of children had variable responses to histamine, 56% to exercise, and 24% to skin tests which were unrelated to exacerbations of chest infection or to changes in pulmonary function. These results show the complex nature of airways hyper-reactivity and allergy in cystic fibrosis, and suggest that 'anti-asthma' therapy is not justified solely on the basis of one positive response to these tests.

Entities:  

Mesh:

Year:  1981        PMID: 7259276      PMCID: PMC1627471          DOI: 10.1136/adc.56.6.455

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Standardization of bronchial inhalation challenge procedures.

Authors:  H Chai; R S Farr; L A Froehlich; D A Mathison; J A McLean; R R Rosenthal; A L Sheffer; S L Spector; R G Townley
Journal:  J Allergy Clin Immunol       Date:  1975-10       Impact factor: 10.793

2.  Contribution of inhomogeneity of lung units to the maximal expiratory flow-volume curve in children with asthma and cystic fibrosis.

Authors:  L I Landau; L M Taussig; P T Macklem; P H Beaudry
Journal:  Am Rev Respir Dis       Date:  1975-06

3.  Contribution of airway collapse to supramaximal expiratory flows.

Authors:  R J Knudson; J Mead; D E Knudson
Journal:  J Appl Physiol       Date:  1974-06       Impact factor: 3.531

4.  The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis.

Authors:  L I Landau; P D Phelan
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

5.  Bronchial lability in cystic fibrosis.

Authors:  G Day; M B Mearns
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

6.  Spectrum of asthma in children. II. Allergic components.

Authors:  K N McNichol; H E Williams
Journal:  Br Med J       Date:  1973-10-06

7.  Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis.

Authors:  R Counahan; M B Mearns
Journal:  Arch Dis Child       Date:  1975-06       Impact factor: 3.791

8.  Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study.

Authors:  H Williams; K N McNicol
Journal:  Br Med J       Date:  1969-11-08

9.  Bronchial lability in children suffering from some diseases of the bronchi.

Authors:  J Haluszka; A Sciślicki
Journal:  Respiration       Date:  1975       Impact factor: 3.580

10.  Immediate hypersensitivity in patients with cystic fibrosis.

Authors:  J D Allan; A D Moss; J C Wallwork; H McFarlane
Journal:  Clin Allergy       Date:  1975-09
View more
  19 in total

1.  Correlates of prepubertal bone mineral density in cystic fibrosis.

Authors:  R H Haslam; D J Borovnicar; D B Stroud; B J Strauss; J E Bines
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

Review 2.  Asthma in cystic fibrosis.

Authors:  Ian M Balfour-Lynn
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 3.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 4.  Airway reactivity in cystic fibrosis.

Authors:  R S Tepper; H Eigen
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Relation between dietary intake and nutritional status in cystic fibrosis.

Authors:  H Anthony; J Bines; P Phelan; S Paxton
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

Review 6.  Exercise recommendations for individuals with cystic fibrosis.

Authors:  S R Boas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

Review 7.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 8.  An overview of the management of cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 9.  Airways reactivity in patients with CF.

Authors:  Miles Weinberger
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 10.  The relationship between atopy and cystic fibrosis.

Authors:  R W Wilmott
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.